PREVALENCE OF ACUTE RHEUMATIC FEVER AMONG YOUTH IN DIFFERENT REGIONS OF UZBEKISTAN AND PATIENT ADHERENCE TO SECONDARY PROPHYLAXIS WITH BENZATHINE PENICILLIN G

Authors

  • Abdullayev Shahzodbek Farxodovich Asia International University Author

Keywords:

Keywords: acute rheumatic fever, benzathine penicillin G, secondary prophylaxis, adherence, compliance, Uzbekistan, rheumatic heart disease, youth

Abstract

Background: Acute rheumatic fever (ARF) remains a significant public health concern in low- and middle-income countries, including Uzbekistan. The effectiveness of secondary prophylaxis with benzathine penicillin G (BPG) is directly dependent on patient adherence; however, compliance data across different regions of Uzbekistan are lacking.

References

1.Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and national burden of rheumaticheartdisease,1990–2015.NEnglJMed.2017;377(8):713722.https://doi.org/10.1056/NEJMoa1603693

2.Bewick T, Greenway M, Soni N, et al. Socioeconomic and geographic determinants of acute rheumatic fever in Central Asian populations: a systematic review. Lancet Reg Health Eur. 2021;4:100073. https://doi.org/10.1016/j.lanepe.2021.100073

3.Gewitz MH, Baltimore RS, Tani LY, et al. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the AmericanHeartAssociation.Circulation.2015;131(20):18061818.https://doi.org/10.1161/CIR.000000000000020

4.RHD Action. Benzathine penicillin G supply and demand study: ensuring access to a critical medicineforRHDprevention.Geneva:WorldHeartFederation;2020.https://rhdaction.org/sites/default/files/BPG-Supply-Study-2020.pdf

5.Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011;3:67–84. https://doi.org/10.2147/CLEP.S12977

6.Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–354. https://doi.org/10.1111/j.1751-7176.2008.07572.x

7.Kumar RK, Antunes MJ, Beaton A, et al. Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American HeartAssociation.Circulation.2020;142(20):e337e357.https://doi.org/10.1161/CIR.0000000000000921

8.Zuhlke LJ, Beaton A, Engel ME, et al. Group A streptococcus, acute rheumatic fever and rheumatic heart disease: epidemiology and clinical considerations. Curr Treat Options Cardiovasc Med. 2017;19(2):15. https://doi.org/10.1007/s11936-017-0513-y

Downloads

Published

2026-07-08